Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImperial Innovations Group Regulatory News (IVO)

  • There is currently no data for IVO

New Commercialisation Centre

6 Oct 2006 07:01

Imperial Innovations Group plc06 October 2006 Imperial Innovations Group plc Establishment of The Consensus Imperial Innovations Commercialisation Centre Imperial Innovations Group plc (AIM: IVO), one of the leading technologytransfer and commercialisation companies in the UK, has today entered into anagreement with Consensus Business Group to establish The Consensus ImperialInnovations Commercialisation Centre (CIICC). This joint initiative will provide an intelligent technology sourcing service toa range of clients, including governments and large corporates, which will beintroduced by Consensus Business Group from within its client base. The Centrewill perform a range of functions from understanding client technology needs toidentifying, packaging and broking technology solutions to meet these needs. Itsspecific activities will include: • Understanding corporate strategies and mapping their business priorities onto emerging technologies of high future importance • Identifying and packaging technology solutions to specific industry needs, drawing on the resource base comprising Imperial College, Imperial Innovations and its spin out companies, the companies in which Consensus Business Group has invested and with whom it has relationships, and other technology sources. • Developing interdisciplinary research and technology development programmes customised for individual companies • Technology workshops for knowledge matching and networking between industry and scientific entrepreneurs The Centre will be funded by Vincos Limited, the UK service company forConsensus Business Group, and managed by Imperial Innovations as an additionalpart of its business. Consensus Business Group is the designated investmentmanager for a major participant in the funding that accompanied the flotation ofImperial Innovations on AIM in July. The initiative re-inforces the closeworking relationship between Consensus Business Group and Imperial Innovations. Initially, services will be provided to technology-intensive governments andcompanies seeking access to next-generation technologies in advanced energysystems, natural resources and environmental sustainability, multifunctionalmaterials, security, aerospace, automotive, information and communicationtechnologies. However, it is expected that this will be expanded into otherareas in due course. Susan Searle, CEO of Imperial Innovations, said, "The establishment of the Consensus Imperial Innovations CommercialisationCentre supports our focus on working with industry and governments ensuring thatthe technologies we develop have real customer application and complements ourexisting routes to market." Vincent Tchenguiz, Chairman of Consensus Business Group, said, "We are delighted to expand our relationship with Imperial Innovations and lookforward to facilitating the introduction of new technologies to ConsensusBusiness Group's portfolio of investments and business partners. Thesetechnologies will also be sourced for the US$250m MASDAR Clean-Tech Fundrecently established by Consensus Business Group with the government of AbuDhabi and Credit Suisse. "We anticipate significant market demand for the technology services that CIICCwill be delivering - a demand that is already evident, both in the UK andglobally." For more information contact: Imperial InnovationsSusan Searle, Chief Executive Officer +44 (0)20 7594 6591Lucy Ahfong, Marketing Communications Executive +44 (0)20 7594 6644 Consensus Business GroupKevin A. Fallon, Investment Director +44 (0)20 7355 7806Sean Bellew +44 (0)20 7355 7957 M:CommunicationsPatrick d'Ancona / Eleanor Williamson +44 (0)20 7153 1539 Notes to Editors About Imperial Innovations Imperial Innovations is one of the UK's leading technology transfer andcommercialisation companies. The company was founded in 1986 and its ordinaryshares admitted to trading on the AIM Market of London Stock Exchange plc inJuly 2006, raising £26 million. The company's integrated approach encompassesthe identification of ideas, protection of intellectual property, developmentand licensing of technology and formation, incubation and investment in spin-outcompanies. A wide range of technologies are commercialised within the areas ofhealthcare, energy, environment and emerging technology trends. Based at Imperial College London, the company has established equity holdings in58 spin-out companies and has completed 90 commercial agreements. ImperialInnovations also commercialises technologies originating from outside ImperialCollege through incubation contracts with the Carbon Trust and WRAP and hasrelationships with a number of multinational corporations. Imperial Innovations has invested in a range of spin-out companies including TheAcrobot Company Limited, Cardiak Limited, deltaDOT Limited, Future Waves PTELimited, HeliSwirl Technologies Limited, InforSense Limited, Lontra Limited,Midaz Lasers Limited, NanoBiodesign Limited, Nexeon Limited, NovaThera Limited,Photobiotics Limited, Thiakis Limited and Veryan Medical Limited. Imperial Innovations currently holds shares in three spin-out companies nowlisted on AIM; fuel cell company, Ceres Power plc, and ParOS plc, a provider ofenergy-saving advanced control solutions, as well as Nanoscience plc, adeveloper of low power integrated circuits and silicon chips, following itsacquisition of spin-out company Toumaz Technology Limited. Website: www.imperialinnovations.co.uk About Consensus Business Group Consensus Business Group ("Consensus" or "CBG") is a multi-faceted principalinvestor in a broad range of activities, including structured finance and theacquisition, management and development of commercial and residential realestate. Consensus has significant shareholdings in property and property relatedcompanies and is now one of the UK's largest private property companies with£5bn of investments in commercial property and a portfolio of around 200,000residential freeholds. Consensus also invests in new technologies and technology start-ups, developinginnovative business models that radically change traditional modes of business.It has made investments in over 180 companies in this area. Consensus has so far invested and committed in excess of £200 million toenvironmentally orientated companies, projects and funds. Consensus intendsaggressively to increase its activities and operations in this sector. CBG CleanTech Investments Limited BVI is a founding partner with the Government of AbuDhabi and Credit Suisse in the MASDAR Clean-Tech Fund. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
7th Jun 20177:00 amRNSForm 8 (OPD) IP Group PLC
6th Jun 201711:19 amRNSForm 8.3 - Touchstone Innovations
5th Jun 201712:46 pmRNSForm 8.3 - Touchstone Innovations Plc
1st Jun 20172:41 pmBUSForm 8.3 - Touchstone Innovations plc
1st Jun 20177:00 amRNSChairman's letter to shareholders
31st May 20175:58 pmRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
31st May 201712:01 pmRNSForm 8.3 - Touchstone Innovations Plc
30th May 20177:00 amRNSForm 8.3 - Touchstone Innovations Plc
26th May 201712:29 pmRNSForm 8.3 - Touchstone Innovations Plc
25th May 201712:15 pmRNSForm 8.3 - Touchstone Innovations Plc
25th May 201712:14 pmRNSForm 8.3 - Touchstone Innovations Plc
25th May 201712:10 pmRNSForm 8.3 - IP Group Plc
24th May 20172:55 pmRNSForm 8.3 - IP Group plc
24th May 20172:52 pmRNSForm 8.3 - Touchstone Innovations plc
24th May 20172:51 pmRNSForm 8.3 - IP Group Plc
24th May 20172:41 pmRNSForm 8.3 - Touchstone Innovations Plc
24th May 20171:15 pmRNSForm 8.3 - Touchstone Innovations Plc
24th May 201711:17 amBUSForm 8 (DD) - Touchstone Innovations Plc.
23rd May 201712:05 pmRNSUpdate on possible offer
23rd May 201711:45 amRNSForm 8.3 - Touchstone Innovations Plc
23rd May 201710:33 amRNSStatement re Possible Offer
23rd May 20177:01 amRNSStatement re Possible Offer
21st Apr 201711:21 amRNSInnovations invests £2.9m in Abzena placing
6th Apr 20177:00 amRNSInnovations provides seed funding for Cardian
31st Mar 20177:00 amRNSHalf Yearly Report
20th Mar 20177:05 amRNSInnovations supports funding round in Pulmocide
16th Mar 20177:00 amRNSInnovations invests in Cell Medica funding round
14th Mar 20177:00 amRNSInnovations supports funding round in Resolver
6th Mar 20177:00 amRNSInnovations leads £12m funding round in Garrison
28th Feb 201711:11 amRNSNotice of Results
21st Feb 20177:03 amRNSCell Medica granted FDA Fast Track designation
26th Jan 20172:00 pmRNSDirectorate Change
5th Jan 20177:00 amRNSChange of name to Touchstone Innovations plc
4th Jan 20179:00 amRNSAppointment of Joint Broker
20th Dec 201612:03 pmRNSPsiOxus signs exclusive licence agreement with BMS
28th Nov 20167:02 amRNSPortfolio company TopiVert receives IND approval
23rd Nov 20165:56 pmRNSGrant of share options
21st Nov 201612:53 pmRNSResult of AGM
28th Oct 201612:30 pmRNSProposed change of name to Touchstone Innovations
28th Oct 201612:29 pmRNSPosting of Annual Report and Notice of AGM
24th Oct 20167:12 amRNSVeryan announces completion of subject enrolment
13th Oct 20167:00 amRNSFinal Results
10th Oct 20161:02 pmRNSCrescendo Biologics sign collaboration with Takeda
6th Oct 20167:02 amRNSFirst patients dosed in TopiVert's Phase IIa study
3rd Oct 201612:10 pmRNSSale of Innovations portfolio company Permasense
21st Sep 20167:06 amRNSInnovations invests £5.1m in Artios Pharma Limited
14th Sep 201612:02 pmRNSNotice of Results
13th Sep 20164:08 pmRNSTR-1: Notification of major interest in shares
9th Sep 20161:15 pmRNSHolding(s) in Company
6th Sep 20164:17 pmRNSEdison issues update on Imperial Innovations (IVO)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.